Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 15Terminated 9Recruiting 8Active not recruiting 6Withdrawn 3Unknown 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 35Thoracic 30Genitourinary 22CNS 18Breast 10Tumor-Agnostic 3Head & Neck 3Sarcoma 1Other solid neoplasm 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Head and Neck Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasms, Squamous Cell 1Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 108Radiotherapy 44Docetaxel 44Radiotherapy, Intensity-Modulated 35Gemcitabine 31Fluorouracil 30camrelizumab 24toripalimab 21Drug Therapy 21Cetuximab 20apatinib 19Paclitaxel 16Carboplatin 16pembrolizumab 14Chemoradiotherapy 14Capecitabine 13sintilimab 12nimotuzumab 12Blood Specimen Collection 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Endostatins 10Cyclophosphamide 9nedaplatin 8endostar protein 8durvalumab 8Nivolumab 8Neoadjuvant Therapy 8Induction Chemotherapy 8fludarabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Radiosurgery × Head & Neck × Clear all
NCT05259319 2023-10-17

IMMUNOs-SBRT

Centre Georges Francois Leclerc

Phase 1 Unknown
92 enrolled
GenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Neoplasms

NCT04435938 2020-12-02

SHINE

McMaster University

Phase 2 Unknown
38 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT04399785 2020-05-22

Phase II Study for Combination of Camrelizumab and SBRT in the First-line Treatment for R/M HNSCC

West China Hospital

Phase 2 Unknown
34 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡